PharmTech spoke with Dr. Asma Patel, VP Global Commercial and Scientific Consulting–Drug Product, to find out how the growth ...

Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...

Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...

A CDMO championing a commitment to patients may sound like lip service or branding, but truly patient-centric CDMOs offer ...

TRS offers a robust solution for analyzing heterogeneous samples, providing comprehensive spectral data essential for ...

Indian drugmakers anticipate a mixed third quarter. Domestic sales and new specialty drugs will drive growth. US generics will see new product boosts. Contract services and APIs are set for moderate ...

Key market opportunities for the global small molecule healthcare contract manufacturing sector include increased demand for ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Alongside expanding the essential medicines list, the government is set to introduce a new pricing policy mandating ...

Frontage Laboratories, Inc., a leading contract development and manufacturing organization (CDMO) announced that its new ...

Bajaj Healthcare reported a net profit of ₹15.67 crore, as compared to ₹11.72 crore in Q3FY25, up 33.7 per cent year-on-year ...

Incyte Corporation is rated Strong Buy with recent execution driving a 56% stock rally and robust revenue growth. Learn more ...